TimesSquare Capital Management
MYOK

TimesSquare Capital Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

TimesSquare Capital Management’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-322,400
Closed -$15.8M – 239
2018
Q4 		$15.8M Sell
322,400
-27,100
-8% -$1.49M 0.14% 188
2018
Q3 		$22.8M Sell
349,500
-74,700
-18% -$4.39M 0.15% 187
2018
Q2 		$21.1M Buy
424,200
+167,885
+65% +$8.13M 0.14% 199
2018
Q1 		$12.5M Buy
+256,315
New +$13.3M 0.09% 219

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BB Biotech
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

TimesSquare Capital Management's MYOK Position: Q1 2019 in Review

TimesSquare Capital Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q1 2019, closing a stake of 322,400 shares — an estimated $15.8M sold.

TimesSquare Capital Management first reported a position in MYOK in Q1 2018 and held it in 4 quarters. The position peaked at $22.8M in Q3 2018. 169 funds tracked by Wall St. Rank hold MYOK as of Q1 2019.

  • TimesSquare Capital Management reported no remaining MyoKardia, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • TimesSquare Capital Management sold 322,400 MyoKardia, Inc. Common Stock shares in Q1 2019, an estimated $15.8M.
  • TimesSquare Capital Management first reported a position in MyoKardia, Inc. Common Stock in Q1 2018 and held it in 4 quarters.
  • TimesSquare Capital Management's MyoKardia, Inc. Common Stock position peaked at $22.8M in Q3 2018.
  • 169 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q1 2019.

Based on TimesSquare Capital Management's 13F filing for Q1 2019, filed 10 May 2019.